VIVUS (VVUS) Enters Third Amedement with Mitsubishi Tanabe Pharma

Article Related SEC Filings (1) Stock Quotes (1) Comments (0)

VIVUS, Inc. (NASDAQ: VVUS) disclosed that on February 21, 2013 it entered into the Third Amendment, or the Amendment, to the Agreement dated as of December 28, 2000 between the Company and Mitsubishi Tanabe Pharma Corporation, formerly Tanabe Seiyaku Co., Ltd., or MTPC, which among other things expands the rights of the Company or its sublicensees to enforce the patents licensed under the Agreement against alleged infringement and clarifies the rights and duties of the parties and the Company’s sublicensees upon termination of the Agreement. In addition, under the Amendment, the Company is obligated to use its best commercial efforts to market STENDRATM (avanafil) in the United States on or before December 31, 2013.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• VIVUS, Inc. (VVUS) to Make Several Scientific Presentations in May
• Ford Motor (F) Will Ramp Production, Halves Two-Week Plant Idling
• Domino's Pizza (DPZ) Added to S&P MidCap 400, Cynosure (CYNO) to S&P SmallCap 600

Create E-mail Alert Related Categories

Corporate News

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?